Prudential PLC Takes Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Key Points

• Prudential PLC has invested approximately $5.38 million in Omega Healthcare Investors, purchasing 141,346 shares, according to its recent SEC filing.
• Several institutional investors have increased their stakes in Omega Healthcare Investors, with 65.25% of the stock now owned by these entities.
• Omega Healthcare Investors reported earnings of $0.77 per share for the last quarter, exceeding analysts' expectations of $0.45, and announced a quarterly dividend of $0.67 per share.

Prudential PLC acquired a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 141,346 shares of the real estate investment trust's stock, valued at approximately $5,382,000.

A number of other large investors have also modified their holdings of the stock. Resona Asset Management Co. Ltd. increased its holdings in Omega Healthcare Investors by 14.3% in the first quarter. Resona Asset Management Co. Ltd. now owns 122,845 shares of the real estate investment trust's stock valued at $4,678,000 after buying an additional 15,405 shares during the last quarter. Nuveen LLC purchased a new position in shares of Omega Healthcare Investors during the first quarter worth about $42,513,000. Virtu Financial LLC purchased a new position in shares of Omega Healthcare Investors during the first quarter worth about $283,000. Entropy Technologies LP purchased a new position in shares of Omega Healthcare Investors during the first quarter worth about $1,396,000. Finally, Invesco Ltd. lifted its position in Omega Healthcare Investors by 122.3% in the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock valued at $92,023,000 after purchasing an additional 1,329,324 shares during the period. Hedge funds and other institutional investors own 65.25% of the company's stock.

Insider Buying and Selling

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company's stock, valued at approximately $749,144.64. The trade was a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Royal Bank Of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Wells Fargo & Company upgraded shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $38.00 to $41.00 in a research report on Monday, July 14th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $42.00.

Omega Healthcare Investors Price Performance

Shares of OHI stock traded up $0.14 during midday trading on Friday, reaching $40.98. 2,151,754 shares of the company traded hands, compared to its average volume of 2,219,108. The firm's 50 day simple moving average is $38.03 and its two-hundred day simple moving average is $37.46. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $44.42. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. The firm has a market cap of $12.09 billion, a PE ratio of 25.30, a price-to-earnings-growth ratio of 2.84 and a beta of 0.66.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%. Omega Healthcare Investors's quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.71 EPS. On average, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.5%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's payout ratio is presently 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.